US Foods

USFD Q4 2025 Earnings

Reported Feb 12, 2026 at 6:48 AM ET · SEC Source

Q4 25 EPS

$1.04

BEAT +3.41%

Est. $1.01

Q4 25 Revenue

$9.80B

MISS 1.02%

Est. $9.90B

vs S&P Since Q4 25

-14.5%

TRAILING MARKET

USFD -5.7% vs S&P +8.9%

Full Year 2025 Results

FY 25 EPS

$3.98

BEAT +0.98%

Est. $3.94

FY 25 Revenue

$39.42B

MISS 0.27%

Est. $39.53B

Market Reaction

Did USFD Beat Earnings? Q4 2025 Results

US Foods delivered a mixed but ultimately encouraging fourth quarter for fiscal 2025, posting adjusted earnings per share of $1.04 against a consensus estimate of $1.01, a beat of 3.41%, even as revenue of $9.80 billion came in just shy of the $9.90 … Read more US Foods delivered a mixed but ultimately encouraging fourth quarter for fiscal 2025, posting adjusted earnings per share of $1.04 against a consensus estimate of $1.01, a beat of 3.41%, even as revenue of $9.80 billion came in just shy of the $9.90 billion analysts had anticipated, representing year-over-year growth of 3.3%. The earnings outperformance was driven in large part by meaningful margin expansion, with Adjusted EBITDA margin widening 35 basis points to 5.0% as the company benefited from distribution productivity improvements and tighter cost management. Independent restaurant case volume growth of 4.1% and gains in healthcare and hospitality segments helped offset a 3.4% decline in chain volumes, reflecting the company's deliberate focus on higher-margin customer categories. Net income surged to $184.00 million, compared to a much weaker year-ago period weighed down by a $124.00 million pension settlement charge. The company also signaled intentions to explore a sale of its Chef'Store cash-and-carry business to sharpen its focus on core foodservice distribution. Looking ahead, management guided for fiscal 2026 Adjusted Diluted EPS growth of 18% to 24%.

Key Takeaways

  • Independent restaurant case volume increased 4.1% in Q4 and 3.3% for the full year
  • Healthcare case volume increased 2.9% in Q4 and 4.4% for the full year
  • Hospitality case volume increased 3.1% in Q4 and 2.9% for the full year
  • Food cost inflation of 1.8% in Q4 and 2.6% for the full year contributed to net sales growth
  • Improved cost of goods sold and inventory management drove gross profit expansion
  • Continued distribution productivity improvement and streamlined administrative processes
  • Adjusted EBITDA margin expanded 35 basis points to 5.0% in Q4 and 30 basis points to 4.9% for the full year
24/7 Wall St

USFD YoY Financials

Q4 2025 vs Q4 2024, source: SEC Filings

“2025 was a strong start to our three year long-range plan. We grew Adjusted EBITDA 11% to a record $1.9 billion, expanded Adjusted EBITDA margin by 30 basis points to 4.9%, and increased Adjusted Diluted EPS 26% to a record $3.98.”

— Dave Flitman, Q4 2025 Earnings Press Release